Segment Reporting

9 Months Ended

Sep. 30, 2012

Segment Reporting [Abstract]

Segment Reporting

Segment Reporting. We report our operations in two operating segments: cardiovascular and endoscopy. Our cardiovascular segment consists of cardiology and radiology medical device products which assist in diagnosing and treating coronary artery disease, peripheral vascular disease and other non-vascular diseases and includes our embolotherapeutic products. Our endoscopy segment consists of gastroenterology and pulmonary medical device products which assist in the palliative treatment of expanding esophageal, tracheobronchial and biliary strictures caused by malignant tumors. We evaluate the performance of our operating segments based on operating income (loss). Financial information relating to our reportable operating segments and reconciliations to the consolidated totals is as follows (in thousands):

	Three Months Ended						Nine Months Ended
	September 30,						September 30,
	2012			2011			2012			2011
Revenues
Cardiovascular	$	92,106		$	87,524		$	280,336		$	259,391
Endoscopy	3,801			2,953			11,721			8,966
Total revenues	95,907			90,477			292,057			268,357
Operating income (loss)
Cardiovascular	9,169			7,405			26,005			30,385
Endoscopy	(87		)	(898		)	(694		)	(2,821		)
Total operating income	$	9,082		$	6,507		$	25,311		$	27,564